{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["COVID-19", "Coronaviruses", "MERS-CoV", "Natural antiviral products", "SARS-CoV"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": [], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "34127903", "DateRevised": {"Year": "2023", "Month": "09", "Day": "21"}, "Article": {"ArticleDate": [{"Year": "2021", "Month": "06", "Day": "10"}], "Language": ["eng"], "ELocationID": ["10.1016/j.sjbs.2021.06.008"], "Journal": {"ISSN": "1319-562X", "JournalIssue": {"Volume": "28", "Issue": "10", "PubDate": {"Year": "2021", "Month": "Oct"}}, "Title": "Saudi journal of biological sciences", "ISOAbbreviation": "Saudi J Biol Sci"}, "ArticleTitle": "Potential natural candidates in the treatment of coronavirus infections.", "Pagination": {"StartPage": "5704", "EndPage": "5713", "MedlinePgn": "5704-5713"}, "Abstract": {"AbstractText": ["Many viral infections do not have treatments or resistant to existing antiviral therapeutic interventions, and a novel strategy is required to combat virus-mediated fatalities. A novel coronavirus (coronavirus disease 2019 [COVID-19]) emerged in Wuhan, China, in late 2019 and rapidly spread across the globe. COVID-19 has impacted human society with life-threatening and unprecedented health, social, and economic issues, and it continues to affect millions of people. More than 5,800 clinical trials are in place worldwide to develop treatments to eradicate COVID-19. Historically, traditional medicine or natural products, such as medicinal plants, marine organisms and microbes, have been efficacious in treating viral infections. Nevertheless, important parameters for natural products, including clinical trial information, pharmacokinetic data, potency and toxicity profiles, <i>in vivo</i> and <i>in vitro</i> data, and product safety require validation. In this review article, an evaluation is performed of the potential application of natural product-based antiviral compounds, including crude extracts and bioactive chemical compounds obtained from medicinal plants, marine organisms, and microbes, to treat the viral infections COVID-19."], "CopyrightInformation": "\u00a9 2021 The Author(s)."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacognosy, Faculty of Pharmacy, Umm Al-Qura University, Makkah 21955, Saudi Arabia."}], "LastName": "Alsenani", "ForeName": "Faisal", "Initials": "F"}], "PublicationTypeList": ["Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "Saudi Arabia", "MedlineTA": "Saudi J Biol Sci", "NlmUniqueID": "101543796", "ISSNLinking": "2213-7106"}, "CoiStatement": "The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Abe M. Complement activation and inflammation. Japanese J. Clin. Pathol. 2006;54(7):744\u2013756.", "ArticleIdList": ["16913666"]}, {"Citation": "Anthony S.J., Johnson C.K., Greig D.J., Kramer S., Che X., Wells H. Global patterns in coronavirus diversity. Virus Evol. 2017;3(1)", "ArticleIdList": ["PMC5467638", "28630747"]}, {"Citation": "Benvenuto D., Giovanetti M., Ciccozzi A., Spoto S., Angeletti S., Ciccozzi M. The 2019-new coronavirus epidemic: evidence for virus evolution. J. Med. Virol. 2020;92(4):455\u2013459.", "ArticleIdList": ["PMC7166400", "31994738"]}, {"Citation": "Chan J.-F.-W., Kok K.-H., Zhu Z., Chu H., To K.-K.-W., Yuan S. Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan. Emerg. Microbes Infections. 2020;9(1):221\u2013236.", "ArticleIdList": ["PMC7067204", "31987001"]}, {"Citation": "Chan J.-F.-W., Yuan S., Kok K.-H., To K.-K.-W., Chu H., Yang J. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster. Lancet Oncol. 2020;395(10223):514\u2013523.", "ArticleIdList": ["PMC7159286", "31986261"]}, {"Citation": "Chang, F.-R., Yen, C.-T., Ei-Shazly, M., Lin, W.-H., Yen, M.-H., Lin, K.-H., et al., 2012. Anti-human coronavirus (anti-HCoV) triterpenoids from the leaves of Euphorbia neriifolia. Natural product communications. 7(11), 1934578X1200701103.", "ArticleIdList": ["23285797"]}, {"Citation": "Chen F., Chan K., Jiang Y., Kao R., Lu H., Fan K. In vitro susceptibility of 10 clinical isolates of SARS coronavirus to selected antiviral compounds. J. Clin. Virol. 2004;31(1):69\u201375.", "ArticleIdList": ["PMC7128415", "15288617"]}, {"Citation": "Chen L., Gui C., Luo X., Yang Q., G\u00fcnther S., Scandella E. Cinanserin is an inhibitor of the 3C-like proteinase of severe acute respiratory syndrome coronavirus and strongly reduces virus replication in vitro. J. Virol. 2005;79(11):7095\u20137103.", "ArticleIdList": ["PMC1112131", "15890949"]}, {"Citation": "Chen Y., Liu Q., Guo D. Emerging coronaviruses: genome structure, replication, and pathogenesis. J. Med. Virol. 2020;92(4):418\u2013423.", "ArticleIdList": ["PMC7167049", "31967327"]}, {"Citation": "Chen C.-J., Michaelis M., Hsu H.-K., Tsai C.-C., Yang K.D., Wu Y.-C. Toona sinensis Roem tender leaf extract inhibits SARS coronavirus replication. J. Ethnopharmacol. 2008;120(1):108\u2013111.", "ArticleIdList": ["PMC7127248", "18762235"]}, {"Citation": "Cheng P.W., Ng L.T., Chiang L.C., Lin C.C. Antiviral effects of saikosaponins on human coronavirus 229E in vitro. Clin. Exp. Pharmacol. Physiol. 2006;33(7):612\u2013616.", "ArticleIdList": ["PMC7162031", "16789928"]}, {"Citation": "Cho J.K., Curtis-Long M.J., Lee K.H., Kim D.W., Ryu H.W., Yuk H.J. Geranylated flavonoids displaying SARS-CoV papain-like protease inhibition from the fruits of Paulownia tomentosa. Bioorg. Med. Chem. 2013;21(11):3051\u20133057.", "ArticleIdList": ["PMC7126831", "23623680"]}, {"Citation": "Cinatl J., Morgenstern B., Bauer G., Chandra P., Rabenau H., Doerr H. Glycyrrhizin, an active component of liquorice roots, and replication of SARS-associated coronavirus. The Lancet. 2003;361(9374):2045\u20132046.", "ArticleIdList": ["PMC7112442", "12814717"]}, {"Citation": "Dhama K., Karthik K., Khandia R., Munjal A., Tiwari R., Rana R. Medicinal and therapeutic potential of herbs and plant metabolites/extracts countering viral pathogens-current knowledge and future prospects. Curr. Drug Metab. 2018;19(3):236\u2013263.", "ArticleIdList": ["29380697"]}, {"Citation": "Drosten C., G\u00fcnther S., Preiser W., Van Der Werf S., Brodt H.-R., Becker S. Identification of a novel coronavirus in patients with severe acute respiratory syndrome. N. Engl. J. Med. 2003;348(20):1967\u20131976.", "ArticleIdList": ["12690091"]}, {"Citation": "Fan H.-H., Wang L.-Q., Liu W.-L., An X.-P., Liu Z.-D., He X.-Q. Repurposing of clinically approved drugs for treatment of coronavirus disease 2019 in a 2019-novel coronavirus-related coronavirus model. Chin. Med. J. 2020", "ArticleIdList": ["PMC7147283", "32149769"]}, {"Citation": "Fields B.N. How do viruses cause different diseases? JAMA. 1983;250(13):1754\u20131756.", "ArticleIdList": ["6310171"]}, {"Citation": "Gelderblom H.R. Medical Microbiology. 4th edition. University of Texas Medical Branch at Galveston; 1996. Structure and classification of viruses.", "ArticleIdList": ["21413309"]}, {"Citation": "Harvey A. Strategies for discovering drugs from previously unexplored natural products. Drug Discovery Today. 2000;5(7):294\u2013300.", "ArticleIdList": ["10856912"]}, {"Citation": "Hemida M.G. In: Animal-Origin Viral Zoonoses. Malik Y.S., Singh R.K., Dhama K., editors. Springer Singapore; Singapore: 2020. The Middle East Respiratory Syndrome Coronavirus (MERS-CoV) pp. 241\u2013254."}, {"Citation": "Ho, T.-Y., Wu, S.-L., Chen, J.-C., Li, C.-C., Hsiang, C.-Y., 2007. Emodin blocks the SARS coronavirus spike protein and angiotensin-converting enzyme 2 interaction. Antiviral Res.74(2), 92\u2013101.", "ArticleIdList": ["PMC7114332", "16730806"]}, {"Citation": "Hoever G., Baltina L., Michaelis M., Kondratenko R., Baltina L., Tolstikov G.A. Antiviral Activity of Glycyrrhizic Acid Derivatives against SARS\u2212 Coronavirus. J. Med. Chem. 2005;48(4):1256\u20131259.", "ArticleIdList": ["15715493"]}, {"Citation": "Huang J., Su D., Feng Y., Liu K., Song Y. Antiviral herbs-present and future. Infectious Disorders-Drug Targets. 2014;14(1):61\u201373.", "ArticleIdList": ["25159303"]}, {"Citation": "Hwang, S.-M., Na, B.-J., Jung, Y.-M., Lim, H.-S., Seo, J.-E., Park, S.-N., et al., 2018. Clinical and Laboratory Findings of MERS-CoV infection. Japanese J. Infect. Dis. 2018: JJID. 2018.187."}, {"Citation": "Jordan, R.E., Adab, P., Cheng, K., 2020. Covid-19: risk factors for severe disease and death. British Medical Journal Publishing Group.", "ArticleIdList": ["32217618"]}, {"Citation": "Keyaerts E., Vijgen L., Pannecouque C., Van Damme E., Peumans W., Egberink H. Plant lectins are potent inhibitors of coronaviruses by interfering with two targets in the viral replication cycle. Antiviral Res. 2007;75(3):179\u2013187.", "ArticleIdList": ["PMC7114093", "17428553"]}, {"Citation": "Kim, D.E., Min, J.S., Jang, M.S., Lee, J.Y., Shin, Y.S., Park, C.M., et al., 2019. Natural bis-benzylisoquinoline alkaloids-tetrandrine, fangchinoline, and cepharanthine, inhibit human coronavirus OC43 infection of MRC-5 human lung cells. 9(11), 696.", "ArticleIdList": ["PMC6921063", "31690059"]}, {"Citation": "Ksiazek T.G., Erdman D., Goldsmith C.S., Zaki S.R., Peret T., Emery S. A novel coronavirus associated with severe acute respiratory syndrome. N. Engl. J. Med. 2003;348(20):1953\u20131966.", "ArticleIdList": ["12690092"]}, {"Citation": "Lau K.-M., Lee K.-M., Koon C.-M., Cheung C.S.-F., Lau C.-P., Ho H.-M. Immunomodulatory and anti-SARS activities of Houttuynia cordata. J. Ethnopharmacol. 2008;118(1):79\u201385.", "ArticleIdList": ["PMC7126383", "18479853"]}, {"Citation": "Lenschow D.J., Lai C., Frias-Staheli N., Giannakopoulos N.V., Lutz A., Wolff T. IFN-stimulated gene 15 functions as a critical antiviral molecule against influenza, herpes, and Sindbis viruses. Proc. Natl. Acad. Sci. 2007;104(4):1371\u20131376.", "ArticleIdList": ["PMC1783119", "17227866"]}, {"Citation": "Li S.-y., Chen C., Zhang H.-q., Guo H.-y., Wang H., Wang L. Identification of natural compounds with antiviral activities against SARS-associated coronavirus. Antiviral Res. 2005;67(1):18\u201323.", "ArticleIdList": ["PMC7114104", "15885816"]}, {"Citation": "Li J.W.-H., Vederas J.C. Drug discovery and natural products: end of an era or an endless frontier? Science. 2009;325(5937):161\u2013165.", "ArticleIdList": ["19589993"]}, {"Citation": "Lin, C.-W., Tsai, F.-J., Tsai, C.-H., Lai, C.-C., Wan, L., Ho, T.-Y., et al., 2005. Anti-SARS coronavirus 3C-like protease effects of Isatis indigotica root and plant-derived phenolic compounds. 68(1), 36\u201342.", "ArticleIdList": ["PMC7114321", "16115693"]}, {"Citation": "Lin S.-C., Ho C.-T., Chuo W.-H., Li S., Wang T.T., Lin C.-C. Effective inhibition of MERS-CoV infection by resveratrol. BMC Infect. Dis. 2017;17(1):1\u201310.", "ArticleIdList": ["PMC5307780", "28193191"]}, {"Citation": "Lu M., Uchil P.D., Li W., Zheng D., Terry D.S., Gorman J. Real-time conformational dynamics of SARS-CoV-2 spikes on virus particles. Cell Host Microbe. 2020", "ArticleIdList": ["PMC7664471", "33242391"]}, {"Citation": "Lu R., Zhao X., Li J., Niu P., Yang B., Wu H. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. The Lancet. 2020;395(10224):565\u2013574.", "ArticleIdList": ["PMC7159086", "32007145"]}, {"Citation": "Luo W., Su X., Gong S., Qin Y., Liu W., Li J. Anti-SARS coronavirus 3C-like protease effects of Rheum palmatum L. extracts. Bioscience trends. 2009;3(4)", "ArticleIdList": ["20103835"]}, {"Citation": "Masters P.S. The molecular biology of coronaviruses. Adv. Virus Res. 2006;66:193\u2013292.", "ArticleIdList": ["PMC7112330", "16877062"]}, {"Citation": "Millet J.K., S\u00e9ron K., Labitt R.N., Danneels A., Palmer K.E., Whittaker G.R. Middle East respiratory syndrome coronavirus infection is inhibited by griffithsin. Antiviral Res. 2016;133:1\u20138.", "ArticleIdList": ["PMC7113895", "27424494"]}, {"Citation": "Mukhtar M., Arshad M., Ahmad M., Pomerantz R.J., Wigdahl B., Parveen Z. Antiviral potentials of medicinal plants. Virus Res. 2008;131(2):111\u2013120.", "ArticleIdList": ["PMC7114233", "17981353"]}, {"Citation": "M\u00fcller C., Schulte F.W., Lange-Gr\u00fcnweller K., Obermann W., Madhugiri R., Pleschka S. Broad-spectrum antiviral activity of the eIF4A inhibitor silvestrol against corona-and picornaviruses. Antiviral Res. 2018;150:123\u2013129.", "ArticleIdList": ["PMC7113723", "29258862"]}, {"Citation": "NCIRD, 2019. MERS in the U.S.: Centers for Disease Control and Prevention; 2019 [updated Aug. 2, 2019. Available from: https://www.cdc.gov/coronavirus/mers/us.html."}, {"Citation": "Newman D.J., Cragg G.M. Natural products as sources of new drugs from 1981 to 2014. J. Nat. Prod. 2016;79(3):629\u2013661.", "ArticleIdList": ["26852623"]}, {"Citation": "Nguyen T.T.H., Woo H.-J., Kang H.-K., Kim Y.-M., Kim D.-W., Ahn S.-A. Flavonoid-mediated inhibition of SARS coronavirus 3C-like protease expressed in Pichia pastoris. Biotechnol. Lett. 2012;34(5):831\u2013838.", "ArticleIdList": ["PMC7087583", "22350287"]}, {"Citation": "O'Keefe B.R., Giomarelli B., Barnard D.L., Shenoy S.R., Chan P.K., McMahon J.B. Broad-spectrum in vitro activity and in vivo efficacy of the antiviral protein griffithsin against emerging viruses of the family Coronaviridae. J. Virol. 2010;84(5):2511\u20132521.", "ArticleIdList": ["PMC2820936", "20032190"]}, {"Citation": "Paraskevis D., Kostaki E.G., Magiorkinis G., Panayiotakopoulos G., Sourvinos G., Tsiodras S. Full-genome evolutionary analysis of the novel corona virus (2019-nCoV) rejects the hypothesis of emergence as a result of a recent recombination event. Infection, Genet. Evolut. 2020;79", "ArticleIdList": ["PMC7106301", "32004758"]}, {"Citation": "Park J.-Y., Kim J.H., Kim Y.M., Jeong H.J., Kim D.W., Park K.H. Tanshinones as selective and slow-binding inhibitors for SARS-CoV cysteine proteases. Bioorg. Med. Chem. 2012;20(19):5928\u20135935.", "ArticleIdList": ["PMC7127169", "22884354"]}, {"Citation": "Peiris J.S.M., Chu C.-M., Cheng V.C.-C., Chan K., Hung I., Poon L.L. Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study. The Lancet. 2003;361(9371):1767\u20131772.", "ArticleIdList": ["PMC7112410", "12781535"]}, {"Citation": "Peiris J., Lai S., Poon L., Guan Y., Yam L., Lim W. Coronavirus as a possible cause of severe acute respiratory syndrome. The Lancet. 2003;361(9366):1319\u20131325.", "ArticleIdList": ["PMC7112372", "12711465"]}, {"Citation": "Pushpa R., Nishant R., Navin K., Pankaj G. Antiviral potential of medicinal plants: an overview. Int. Res. J. Pharm. 2013;4(6):8\u201316."}, {"Citation": "Ryu Y.B., Jeong H.J., Kim J.H., Kim Y.M., Park J.-Y., Kim D. Biflavonoids from Torreya nucifera displaying SARS-CoV 3CLpro inhibition. Bioorg. Med. Chem. 2010;18(22):7940\u20137947.", "ArticleIdList": ["PMC7126309", "20934345"]}, {"Citation": "Sahu A., Lambris J.D. Complement inhibitors: a resurgent concept in anti-inflammatory therapeutics. Immunopharmacology. 2000;49(1\u20132):133\u2013148.", "ArticleIdList": ["10904113"]}, {"Citation": "Sarma V.J., Huber-Lang M., Ward P.A. Complement in lung disease. Autoimmunity. 2006;39(5):387\u2013394.", "ArticleIdList": ["16923538"]}, {"Citation": "Schwarz S., Sauter D., Wang K., Zhang R., Sun B., Karioti A. Kaempferol derivatives as antiviral drugs against the 3a channel protein of coronavirus. Planta Med. 2014;80(02\u201303):177.", "ArticleIdList": ["PMC7171712", "24458263"]}, {"Citation": "Shen Y.-C., Wang L.-T., Khalil A.T., Chiang L.C., Cheng P.-W. Bioactive pyranoxanthones from the roots of Calophyllum blancoi. Chem. Pharm. Bull. 2005;53(2):244\u2013247.", "ArticleIdList": ["15684529"]}, {"Citation": "Siddell, S.G., Walker, P.J., Lefkowitz, E.J., Mushegian, A.R., Adams, M.J., Dutilh, B.E., et al., 2019. Additional changes to taxonomy ratified in a special vote by the International Committee on Taxonomy of Viruses Archives of virology. 164(3), 943\u2013946.", "ArticleIdList": ["30663020"]}, {"Citation": "Singhal T. A review of coronavirus disease-2019 (COVID-19) Indian J. Pediatr. 2020;87:1\u20136.", "ArticleIdList": ["PMC7090728", "32166607"]}, {"Citation": "Snijder E.J., Bredenbeek P.J., Dobbe J.C., Thiel V., Ziebuhr J., Poon L.L. Unique and conserved features of genome and proteome of SARS-coronavirus, an early split-off from the coronavirus group 2 lineage. J. Mol. Biol. 2003;331(5):991\u20131004.", "ArticleIdList": ["PMC7159028", "12927536"]}, {"Citation": "Strohl W.R. The role of natural products in a modern drug discovery program. Drug Discovery Today. 2000;5(2):39.", "ArticleIdList": ["10652450"]}, {"Citation": "Tyrrell, D.A., Myint, S.H., 1996. Coronaviruses. Medical Microbiology, 4th edition. University of Texas Medical Branch at Galveston.", "ArticleIdList": ["21413266"]}, {"Citation": "van Boheemen S., de Graaf M., Lauber C., Bestebroer T.M., Raj V.S., Zaki A.M. Genomic characterization of a newly discovered coronavirus associated with acute respiratory distress syndrome in humans. MBio. 2012;3(6)", "ArticleIdList": ["PMC3509437", "23170002"]}, {"Citation": "Wan Y., Shang J., Graham R., Baric R.S., Li F. Receptor recognition by the novel coronavirus from Wuhan: an analysis based on decade-long structural studies of SARS coronavirus. J. Virol. 2020;94(7)", "ArticleIdList": ["PMC7081895", "31996437"]}, {"Citation": "Wen C.-C., Shyur L.-F., Jan J.-T., Liang P.-H., Kuo C.-J., Arulselvan P. Traditional Chinese medicine herbal extracts of Cibotium barometz, Gentiana scabra, Dioscorea batatas, Cassia tora, and Taxillus chinensis inhibit SARS-CoV replication. J. Traditional Complement. Med. 2011;1(1):41\u201350.", "ArticleIdList": ["PMC3942999", "24716104"]}, {"Citation": "WHO, 2020. Middle East respiratory syndrome coronavirus (MERS-CoV) \u2013 Saudi Arabia 2020. Available from: https://www.who.int/csr/don/05-may-2020-mers-saudi-arabia/en/."}, {"Citation": "WHO, 2021. Coronavirus disease (COVID-19) pandemic: World Health Organization; 2021 [Available from: https://www.who.int/emergencies/diseases/novel-coronavirus-2019."}, {"Citation": "Wong A.C., Li X., Lau S.K., Woo P.C. Global epidemiology of bat coronaviruses. Viruses. 2019;11(2):174.", "ArticleIdList": ["PMC6409556", "30791586"]}, {"Citation": "Wu, A., Peng, Y., Huang, B., Ding, X., Wang, X., Niu, P., et al. Genome composition and divergence of the novel coronavirus (2019-nCoV) originating in China. Cell Host and Microbe 2020.", "ArticleIdList": ["PMC7154514", "32035028"]}, {"Citation": "Wu C.-J., Jan J.-T., Chen C.-M., Hsieh H.-P., Hwang D.-R., Liu H.-W. Inhibition of severe acute respiratory syndrome coronavirus replication by niclosamide. Antimicrobial Agents Chemother. 2004;48(7):2693\u20132696.", "ArticleIdList": ["PMC434198", "15215127"]}, {"Citation": "Yeung M.-L., Yao Y., Jia L., Chan J.F., Chan K.-H., Cheung K.-F. MERS coronavirus induces apoptosis in kidney and lung by upregulating Smad7 and FGF2. Nat. Microbiol. 2016;1(3):1\u20138.", "ArticleIdList": ["PMC7097571", "27572168"]}, {"Citation": "Zhang T., Chen D. Anticomplementary principles of a Chinese multiherb remedy for the treatment and prevention of SARS. J. Ethnopharmacol. 2008;117(2):351\u2013361.", "ArticleIdList": ["PMC7126446", "18400428"]}, {"Citation": "Ziebuhr, J., Baric, R., Baker, S., de Groot, R., Drosten, C., Gulyaeva, A., et al. Reorganization of the family Coronaviridae into two families, Coronaviridae (including the current subfamily Coronavirinae and the new subfamily Letovirinae) and the new family Tobaniviridae (accommodating the current subfamily Torovirinae and three other subfamilies), revision of the genus rank structure and introduction of a new subgenus rank. International Committee on Taxonomy of Viruses. 2018."}, {"Citation": "Ziebuhr, J., 2019. Create ten new species a new genus in the subfamily Orthocoronavirinae of the family Coronaviridae five new species a new genus in the subfamily Serpentovirinae of the family Tobaniviridae. Proposal 2019021 S\u201c Ac v1. 2019."}], "ReferenceList": []}], "History": [{"Year": "2021", "Month": "2", "Day": "14"}, {"Year": "2021", "Month": "5", "Day": "31"}, {"Year": "2021", "Month": "6", "Day": "2"}, {"Year": "2021", "Month": "6", "Day": "16", "Hour": "6", "Minute": "0"}, {"Year": "2021", "Month": "6", "Day": "16", "Hour": "6", "Minute": "1"}, {"Year": "2021", "Month": "6", "Day": "15", "Hour": "6", "Minute": "52"}, {"Year": "2021", "Month": "6", "Day": "10"}], "PublicationStatus": "ppublish", "ArticleIdList": ["34127903", "PMC8190277", "10.1016/j.sjbs.2021.06.008", "S1319-562X(21)00468-X"]}}], "PubmedBookArticle": []}